Core Viewpoint - Chevron Corp (CVX) has reached a new 52-week high at $168.96, with a year-to-date increase of 14.49% and a monthly rise of 7.21%, prompting investors to consider whether to invest now or wait for a potential pullback [1] Group 1: Investment Sentiment - Warren Buffett's Berkshire Hathaway holds 118.6 million shares of CVX, representing 6.42% of its portfolio and 6.60% of Chevron's outstanding shares, indicating strong confidence in the company [1] - The stock's technical indicators are bullish, supported by Buffett's long-term conviction and solid upward momentum [4] Group 2: Technical Analysis - CVX stock is trading at $167.97, above key moving averages, with a Moving Average Convergence Divergence (MACD) of 3.25, suggesting a bullish trend [2] - The Relative Strength Index (RSI) is at 70.38, indicating that the stock is in overbought territory, which may suggest a cooling off period ahead [2] - Despite being above the five-, 20-, and 50-day exponential moving averages, there are signs of slight selling pressure, indicating that traders may be locking in profits [3] Group 3: Investment Strategy - While Chevron shows bullish technical indicators, the overbought RSI suggests that waiting for a slight pullback could provide a better entry point for investors [4] - CVX remains a strong contender for those looking to invest in the energy sector, but caution is advised when chasing highs due to potential risks [4]

Group 1: Berkshire Hathaway Inc (Class B) - Berkshire Hathaway has reached an all-time high of $537.63, indicating strong bullish momentum [1] - The stock is above its eight, 20, 50, and 200-day simple moving averages, with a MACD reading of 11.98 supporting upward movement [1] - However, the Relative Strength Index (RSI) is at 71.59, suggesting overbought conditions and potential near-term cooling [2] Group 2: RTX Corporation - RTX Corporation has achieved a new 52-week high of $135.41, reflecting a steady upward trend [2] - The stock remains above all key moving averages, with a MACD reading of 2.22 confirming the uptrend [3] - An RSI of 63.80 indicates that the stock has not yet reached overbought levels, suggesting further potential for growth [3] Group 3: Kinross Gold Corporation - Kinross Gold has hit a 52-week peak of $12.33, benefiting from soaring gold prices [4] - The stock is positioned well above its eight, 20, 50, and 200-day simple moving averages, with a MACD reading of 0.33 reinforcing positive momentum [4] - An RSI of 64.46 shows that while Kinross is not in immediate danger of overheating, there is increasing selling pressure that could lead to a pullback [5]

Core Viewpoint - Tesla Inc. stock has rebounded over 10% after a significant decline, driven by renewed interest in its Full Self-Driving (FSD) rollout in China, easing tariff concerns, and technical support levels [1][2][3] Group 1: Stock Performance - Despite the recent surge, Tesla's stock is down 28% year-to-date and 17% over the past month, indicating a bearish trend [1] - The stock trades below its five-day, 20-day, and 50-day exponential moving averages, with a current price of $273.00 [6] - The eight-day simple moving average (SMA) is at $243.48, and the 20-day SMA is at $258.95, suggesting some bullish momentum [6] Group 2: Key Catalysts - The rollout of FSD in China is seen as a potential catalyst for growth, although it remains uncertain if Chinese consumers will pay a premium compared to local competitor BYD, which offers similar technology for free [2] - Reports of former President Donald Trump easing tariff threats are viewed positively, as Tesla has significant exposure to the Chinese electric vehicle market [3] Group 3: Future Outlook - The sustainability of Tesla's rally will depend on continued buying pressure and whether fundamental catalysts like the FSD launch and tariff relief can outweigh bearish technical signals [4] - The upcoming first-quarter delivery report on April 2 is anticipated as a critical moment for investors [4] - Current technical indicators, such as the Moving Average Convergence Divergence (MACD) at negative 24.83 and a Relative Strength Index (RSI) of 48.01, suggest mixed sentiment [6]

Core Viewpoint - Johnson & Johnson's stock has recently exhibited a bullish technical pattern known as a Golden Cross, indicating potential long-term upside, supported by a significant breakthrough in lung cancer treatment [1][4]. Technical Analysis - The stock price of Johnson & Johnson is currently at $162.37, with short-term moving averages showing mixed signals. The 8-day simple moving average is at $163.37 and the 20-day simple moving average is at $164.45, indicating slight selling pressure. However, the 50-day simple moving average at $156.24 and the 200-day simple moving average at $155.72 support a bullish trend [1]. - The Moving Average Convergence Divergence (MACD) indicator stands at 1.74, reinforcing the bullish outlook, while the Relative Strength Index (RSI) is at 52.33, indicating the stock is in neutral territory [2]. Breakthrough in Cancer Treatment - Johnson & Johnson announced a significant milestone in lung cancer treatment, with the Phase 3 MARIPOSA study showing that the combination therapy of RYBREVANT (amivantamab-vmjw) and LAZCLUZE (lazertinib) significantly improved survival rates for patients with advanced non-small cell lung cancer [2]. - The European Medicines Agency is considering approval for this breakthrough, which could serve as a long-term revenue driver for the company [3]. Investor Considerations - The Golden Cross pattern suggests a long-term bullish trend for Johnson & Johnson's stock, although short-term resistance levels may pose challenges. The combination of a promising cancer treatment and bullish technical signals provides both fundamental and technical reasons for investors to monitor the company closely [4].

General Motors Co GM is nearing a critical technical level that could trouble investors. Despite a promising partnership with Nvidia Corp NVDA to integrate AI into vehicle development, GM stock is approaching a Death Cross — a bearish signal that suggests potential downward momentum. Chart created using Benzinga ProGM Stock Chart Flashes CautionGM stock is teetering on the edge. The stock was trading at $49.16 at the time of writing, slipping below key moving averages:GM stock’s 50-day simple moving average ...

Core Viewpoint - JD.com is set to report its fourth-quarter earnings, with Wall Street expecting earnings per share (EPS) of 80 cents and revenues of $45.16 billion, indicating strong market anticipation for the results [1] Group 1: Stock Performance - JD.com stock has increased by 101.96% over the past year and 26.50% year-to-date [1] - The current stock price is $42.94, which is above key support levels, including the eight-day simple moving average at $41.31, the 20-day at $40.77, and the 50-day at $38.56, indicating a strong bullish trend [2] - The stock is also well above its 200-day simple moving average of $33.89, suggesting strong long-term support [3] Group 2: Technical Indicators - The Moving Average Convergence Divergence (MACD) indicator is at 0.78, indicating continued upward momentum [3] - The Relative Strength Index (RSI) is at 57.75, suggesting the stock is in neutral territory, allowing for further gains [3] Group 3: Analyst Ratings and Price Targets - The consensus analyst rating for JD.com stock is currently a Buy, with a price target of $42 [4] - Analysts from Barclays, Bernstein, and Citigroup have an average price target of $50.67, implying a potential upside of 16.76% for the stock [4] - At the time of publication, JD.com stock was up 6.35% at $43.55 [4]

Core Viewpoint - Salesforce Inc is set to report its fourth-quarter earnings, with Wall Street expecting an EPS of $2.61 and revenues of $10.04 billion, while the stock has shown a 2.76% increase over the past year but a 6.64% decline year-to-date [1] Stock Performance - Salesforce stock is currently priced at $308.35, indicating it is in bearish territory as it trades below its five-day, 20-day, and 50-day exponential moving averages (EMA), suggesting a strong downward trend [2] - The stock's eight-day simple moving average (SMA) is $316.35, the 20-day SMA is $328.28, and the 50-day SMA is $332.95, all reinforcing the bearish setup and short-term weakness [2] Technical Indicators - The stock remains above its 200-day SMA of $289.55, which provides a longer-term bullish signal [3] - Momentum indicators show a negative trend, with the Moving Average Convergence Divergence (MACD) at -6.90 indicating negative momentum, and the Relative Strength Index (RSI) at 34.92 suggesting the stock is nearing oversold conditions [3] Analyst Ratings - The consensus analyst rating for Salesforce stock is currently a Buy, with a price target of $378.03, indicating a potential upside of 26.57% according to recent ratings from Citigroup, Citizens Capital, and BMO Capital [5] - At the time of publication, Salesforce stock was trading at $308.12 [5]